Heart Failure Clinical Trials in Stanford, California
8 recruitingStanford, California
Showing 1–8 of 8 trials
Recruiting
Not Applicable
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Heart FailureHeart TransplantTransplant; Failure, Heart
XVIVO Perfusion60 enrolled14 locationsNCT06895070
Recruiting
Phase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Heart FailureHeart Failure With Reduced Ejection Fraction
Cytokinetics1,800 enrolled183 locationsNCT06736574
Recruiting
Not Applicable
Identifying Markers of Exercise Training in Heart Failure
Heart Failure
Stanford University90 enrolled1 locationNCT05696652
Recruiting
Not Applicable
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
Single VentricleHeart Failure Congenital
Stanford University50 enrolled2 locationsNCT06150950
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Heart FailureArrhythmiaBradycardia+1 more
Medtronic20,000 enrolled318 locationsNCT00271180
Recruiting
Phase 3
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Heart FailureDiabetes Mellitus, Type 1Diabetic Nephropathies+1 more
Alessandro Doria150 enrolled18 locationsNCT06217302
Recruiting
Phase 2
Study of JK07 in Patients With Chronic Heart Failure
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction
Salubris Biotherapeutics Inc282 enrolled62 locationsNCT06369298
Recruiting
Phase 1Phase 2
Mechanisms of Semaglutide Therapy in Heart Failure Patients
Heart FailureObesity
University Medical Centre Ljubljana10 enrolled3 locationsNCT06541509